Acylation of ghrelin is increased in heart failure and decreases post heart transplantation

References

• Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29:2641–50.
   PubMed Web of Science ®Google Scholar
• Williams JJ, Lund LH, LaManca J, Kunavarapu C, Cohen DJ, Heshka S, et al. Excessive weight gain in cardiac transplant recipients. J Heart Lung Transplant. 2006;25: 36–41.
   PubMed Web of Science ®Google Scholar
• Lund LH, Williams JJ, Freda P, LaManca JJ, LeJemtel TH, Mancini DM. Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation. Eur J Heart Fail. 2009;11:789–94.
   PubMed Web of Science ®Google Scholar
• Delporte C. Structure and physiological actions of ghrelin. Scientifica. 2013;2013:518909.
   PubMedGoogle Scholar
• Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908–13.
   PubMed Web of Science ®Google Scholar
• Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 2002;87:240–4.
   PubMed Web of Science ®Google Scholar
• Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623–30.
   PubMed Web of Science ®Google Scholar
• Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation. 2004; 110:3674–9.
   PubMed Web of Science ®Google Scholar
• Lund LH, Freda P, Williams JJ, LaManca JJ, LeJemtel TH, Mancini DM. Growth hormone resistance in severe heart failure resolves after cardiac transplantation. Eur J Heart Fail. 2009;11:525–8.
   PubMed Web of Science ®Google Scholar
• Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008;132: 387–96.
   PubMed Web of Science ®Google Scholar
• Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, et al. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab. 2004; 89:3062–5.
   PubMed Web of Science ®Google Scholar
• Stengel A, Goebel M, Wang L, Reeve JR Jr, Tache Y, Lambrecht NW. Lipopolysaccharide differentially decreases plasma acyl and desacyl ghrelin levels in rats: potential role of the circulating ghrelin-acylating enzyme GOAT. Peptides. 2010;31:1689–96.
   PubMed Web of Science ®Google Scholar
• Nakahara T, Harada T, Yasuhara D, Shimada N, Amitani H, Sakoguchi T, et al. Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry. 2008;64:252–5.
   PubMed Web of Science ®Google Scholar
• Buscher AK, Buscher R, Hauffa BP, Hoyer PF. Alterations in appetite-regulating hormones influence protein-energy wasting in pediatric patients with chronic kidney disease. Pediatr Nephrol. 2010;25:2295–301.
   PubMed Web of Science ®Google Scholar
• Itoh T, Nagaya N, Yoshikawa M, Fukuoka A, Takenaka H, Shimizu Y, et al. Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:879–82.
   PubMed Web of Science ®Google Scholar
• Tacke F, Brabant G, Kruck E, Horn R, Schoffski P, Hecker H, et al. Ghrelin in chronic liver disease. J Hepatol. 2003;38:447–54.
   PubMed Web of Science ®Google Scholar
• Garcia JM, Garcia-Touza M, Hijazi RA, Taffet G, Epner D, Mann D, et al. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab. 2005;90:2920–6.
   PubMed Web of Science ®Google Scholar
• Barazzoni R, Zanetti M, Ferreira C, Vinci P, Pirulli A, Mucci M, et al. Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. J Clin Endocrinol Metab. 2007;92:3935–40.
   PubMed Web of Science ®Google Scholar
• Lund LH, Freda P, Williams JJ, LaManca JJ, LeJemtel TH, Mancini DM. Leptin resistance after heart transplantation. Eur J Heart Fail. 2010;12:516–20.
   PubMed Web of Science ®Google Scholar
• Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll LL, et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation. 2004;109:2221–6.
   PubMed Web of Science ®Google Scholar
• Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol. 2002; 159:1029–37.
   PubMed Web of Science ®Google Scholar
• Nagaya N, Miyatake K, Uematsu M, Oya H, Shimizu W, Hosoda H, et al. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab. 2001;86:5854–9.
   PubMed Web of Science ®Google Scholar
• Toshinai K, Yamaguchi H, Sun Y, Smith RG, Yamanaka A, Sakurai T, et al. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology. 2006;147:2306–14.
   PubMed Web of Science ®Google Scholar
• Asakawa A, Inui A, Fujimiya M, Sakamaki R, Shinfuku N, Ueta Y, et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut. 2005;54:18–24.
   PubMed Web of Science ®Google Scholar
• Moazed B, Quest D, Gopalakrishnan V. Des-acyl ghrelin fragments evoke endothelium-dependent vasodilatation of rat mesenteric vascular bed via activation of potassium channels. Eur J Pharmacol. 2009;604:79–86.
   PubMed Web of Science ®Google Scholar
• Ozcan B, Neggers SJ, Miller AR, Yang HC, Lucaites V, Abribat T, et al. Does des-acyl ghrelin improve glycemic control in obese diabetic subjects by decreasing acylated ghrelin levels? Eur J Endocrinol. 2014;170:799–807.
   PubMed Web of Science ®Google Scholar
• Beiras-Fernandez A, Kaczmarek I, Schmoeckel M, Beiras A, Vicol C, Reichart B. Expression of Ghrelin, a novel cardiovascular hormone, and its peptide in the myocardium of patients undergoing heart transplantation. J Heart Lung Transpl. 2007;26:S84–5.
   Web of Science ®Google Scholar
• Liu J, Prudom CE, Nass R, Pezzoli SS, Oliveri MC, Johnson ML, et al. Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J Clin Endocrinol Metab. 2008;93: 1980–7.
   PubMed Web of Science ®Google Scholar
• Blatnik M, Soderstrom CI, Dysinger M, Fraser SA. Prandial ghrelin attenuation provides evidence that des-acyl ghrelin may be an artifact of sample handling in human plasma. Bioanalysis. 2012;4:2447–55.
   PubMed Web of Science ®Google Scholar
• Delhanty PJ, Huisman M, Julien M, Mouchain K, Brune P, Themmen AP, et al. The acylated (AG) to unacylated (UAG) ghrelin ratio in esterase inhibitor-treated blood is higher than previously described. Clin Endocrinol (Oxf). 2014;1–5
   Google Scholar